uniQure

YTD

ALL

Trade uniQure 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About QURE

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems.

CEO

Matthew C. Kapusta

CEOMatthew C. Kapusta

Employees

209

Employees209

Headquarters

Amsterdam, Noord-Holland

HeadquartersAmsterdam, Noord-Holland

Founded

2012

Founded2012

Employees

209

Employees209

QURE Key Statistics

Market cap

2.11B

Market cap2.11B

Price-Earnings ratio

-8.75

Price-Earnings ratio-8.75

Dividend yield

—

Dividend yield—

Average volume

1.66M

Average volume1.66M

High today

$66.56

High today$66.56

Low today

$11.24

Low today$11.24

Open price

$22.91

Open price$22.91

Volume

30.68M

Volume30.68M

52 Week high

$71.50

52 Week high$71.50

52 Week low

$5.35

52 Week low$5.35

QURE News

TipRanks 11h

Why Is UniQure Stock Down 60% Today?

UniQure (QURE) stock plummeted on Monday after the U.S. Food and Drug Administration (FDA) backtracked on plans to support the company’s filing of a Biologics L...

Analyst ratings

92%

of 13 ratings

Buy

92.3%

Hold

7.7%

Sell

People also own

Based on the portfolios of people who own QURE. This list is generated using Robinhood data, and it’s not a recommendation.